LRMR — Larimar Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Larimar Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	92.6	70.1	118	86.8	183
Net Total Receivables	—	0.208	0	—	1.05
Prepaid Expenses
Total Current Assets	98	72.2	121	90.2	195
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.98	4.46	3.69	3.76	3.72
Other Long Term Assets
Total Assets	105	78.7	126	95.9	200
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	8.99	8.85	10.7	9.51	24.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15	14.3	15.5	14.2	28.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	89.7	64.4	111	81.7	172
Total Liabilities & Shareholders' Equity	105	78.7	126	95.9	200
Total Common Shares Outstanding